Patients receiving abiraterone acetate 1 000 mg. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases3

Prostatic Neoplasms, Castration-Resistant Prostatic Neoplasms Neoplasms, Hormone-Dependent

Chemicals and Drugs18

Androstenols Phenylthiohydantoin Steroid 17-alpha-Hydroxylase Androgen Antagonists Androstadienes Acetates Androgens Prostate-Specific Antigen Taxoids Antineoplastic Agents, Hormonal Prednisone Antineoplastic Agents Receptors, Androgen Androgen Receptor Antagonists Tetradecanoylphorbol Acetate Tissue Extracts Acetate Kinase Dihydrotestosterone

Analytical, Diagnostic and Therapeutic Techniques and Equipment4

Orchiectomy Castration Treatment Outcome Clinical Trials, Phase III as Topic

Phenomena and Processes2

Biosynthetic Pathways Drug Resistance, Neoplasm

Health Care3

Treatment Outcome Clinical Trials, Phase III as Topic Budgets

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Health Care

Androstenols Phenylthiohydantoin Steroid 17-alpha-Hydroxylase Orchiectomy Prostatic Neoplasms, Castration-Resistant Androgen Antagonists Prostatic Neoplasms Castration Androstadienes Acetates Androgens Prostate-Specific Antigen Neoplasms, Hormone-Dependent Taxoids Antineoplastic Agents, Hormonal Prednisone Antineoplastic Agents Receptors, Androgen Treatment Outcome Androgen Receptor Antagonists Tetradecanoylphorbol Acetate Biosynthetic Pathways Tissue Extracts Clinical Trials, Phase III as Topic Budgets Drug Resistance, Neoplasm Acetate Kinase Dihydrotestosterone

No FAQ available that match "patients receiving abiraterone acetate 1 000 mg"